Gastric Balloons Market Report
First published: 07 October 2024 | Last updated: 25 May 2026 | Report Code: gastric-balloons
Gastric Balloons Market — USD $3.0 Billion in 2023, Growing to USD 6.01null by 2033 at 7.0% CAGR
This report provides a comprehensive analysis of the gastric balloons market from 2023 to 2033, detailing market size, trends, technological advancements, and regional insights to aid stakeholders in strategic decision-making.
Key Takeaways
- Global market expands from $3.00 Billion in 2023 to $6.01 Billion by 2033 at a 7% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Product portfolios include intragastric balloons and branded offerings such as ORBERA and Revirol.
- Hospitals, clinics, and home care settings are primary end-users supporting device uptake.
- Major vendors listed include Apollo Endosurgery, Ethicon Inc., and Allergan.
Gastric Balloons Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report examines the gastric balloons sector from 2023 to 2033, documenting growth from $3.00 Billion to $6.01 Billion at a 7% CAGR. Demand is driven by rising interest in non-surgical weight management and broader clinical acceptance. The analysis covers product variations including intragastric balloons and branded devices such as ORBERA and Revirol, distribution channels from direct sales to online platforms, and end-use across hospitals, clinics, and home care. Regional breakdowns detail market evolution in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Competitive coverage highlights leading suppliers including Apollo Endosurgery, Ethicon Inc., and Allergan. The report also reviews regulatory and reimbursement influences, technological improvements affecting device safety and comfort, and stakeholder engagement patterns that shape adoption over the forecast period.
Key Growth Drivers
- Increased demand for minimally invasive weight management alternatives among patient populations.
- Broader clinical acceptance and improvements in device safety and comfort supporting clinician adoption.
- Expanded availability through hospitals, clinics, and home care distribution channels.
- Brand recognition and product offerings from established firms such as Apollo Endosurgery, Ethicon Inc., and Allergan.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $3.00 Billion |
| CAGR (2023-2033) | 7.0% |
| 2033 Market Size | $6.01 Billion |
| Top Companies | Apollo Endosurgery, Ethicon Inc., Allergan |
| Published Date | 07 October 2024 |
| Last Modified Date | 25 May 2026 |
Gastric Balloons Market Overview
Customize Gastric Balloons Market Report market research report
- ✔ Get in-depth analysis of Gastric Balloons market size, growth, and forecasts.
- ✔ Understand Gastric Balloons's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Gastric Balloons
What is the Market Size & CAGR of Gastric Balloons Market Report market in 2023?
Gastric Balloons Industry Analysis
Gastric Balloons Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Gastric Balloons Market Report Market Analysis Report by Region
Europe Gastric Balloons Market Report:
Europe grows from $0.78 Billion in 2023 to $1.56 Billion in 2033. Expansion in this region is shaped by increasing acceptance of non-invasive interventions, regulatory developments, and improved access through hospitals and specialty clinics.Asia Pacific Gastric Balloons Market Report:
Asia Pacific grows from $0.61 Billion in 2023 to $1.23 Billion in 2033. Market progress reflects rising patient awareness, broader healthcare access, and growing clinical adoption of less invasive weight management tools.North America Gastric Balloons Market Report:
North America is largest regional market, rising from $1.15 Billion in 2023 to $2.31 Billion in 2033. Regional momentum is linked to established clinical infrastructure, higher awareness of non-surgical weight-loss options, and strong presence of leading suppliers supporting product availability.South America Gastric Balloons Market Report:
Latin America grows from $0.23 Billion in 2023 to $0.46 Billion in 2033. Growth drivers include expanding healthcare services, increasing recognition of obesity-related treatments, and improving distribution networks in clinical settings.Middle East & Africa Gastric Balloons Market Report:
Middle East and Africa grows from $0.23 Billion in 2023 to $0.45 Billion in 2033. Regional gains are tied to enhanced healthcare capacity, growing awareness of non-surgical therapies, and gradual uptake across hospitals and clinics.Tell us your focus area and get a customized research report.
Research Methodology
Gastric Balloons Market Analysis By Product
Overall, the gastric balloons market saw intragastric balloons lead with a size of $2.03 billion in 2023, projected to reach $4.07 billion by 2033 while holding a 67.72% market share. Specific brands like ORBERA and Revirol are crucial market players, having values of $0.65 billion and $0.32 billion respectively in 2023, both expected to show significant growth by 2033.
Gastric Balloons Market Analysis By Application
The applications of gastric balloons include weight management, pre-operative assistance, and rehabilitation. Weight management significantly dominates this segment, valued at $2.03 billion in 2023, while pre-operative assistance and rehabilitation hold smaller portions of $0.65 billion and $0.32 billion respectively, with all segments anticipated to grow by 2033.
Gastric Balloons Market Analysis By End User
Hospitals, clinics, and home care settings are the primary end-users. The hospital segment leads with $2.03 billion in 2023, projected to grow to $4.07 billion by 2033. Clinics follow with $0.65 billion in 2023, doubling by 2033, while home care demonstrates an emerging potential in providing weight management solutions.
Gastric Balloons Market Analysis By Distribution Channel
Direct sales, online sales, and third-party distributors are crucial distribution channels in the gastric balloons market. Direct sales dominate with revenues of $2.03 billion in 2023, while online sales and third-party distributors represent $0.65 billion and $0.32 billion respectively. All segments are expected to expand significantly towards 2033.
Gastric Balloons Market Analysis By End User Demographics
The primary demographic for gastric balloons includes adult patients, accounting for 87.5% of the market, with an expected growth from $2.63 billion in 2023 to $5.26 billion by 2033. Pediatric patients represent a smaller segment but are also showing potential with a projected increase in demand.
Gastric Balloons Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Gastric Balloons Industry
Apollo Endosurgery:
A leading global provider of minimally invasive medical devices, Apollo specializes in endoscopic gastric balloons and is driving innovation in the weight management sector.Ethicon Inc.:
A subsidiary of Johnson & Johnson, Ethicon offers advanced medical devices, including gastric balloons that are instrumental in non-invasive weight loss solutions.Allergan:
Known for its aesthetic products, Allergan also plays a key role in the gastric balloons market with its ORBERA product, which helps reduce obesity in patients.We're grateful to work with incredible clients.
FAQs
What is the market size of the gastric balloons industry in 2023?
The market size in 2023 is reported as $3.00 Billion. This figure reflects global sales and forms the baseline for projections through the 2023 to 2033 forecast period.
How big will the market be in 2033?
Projected market value for 2033 is $6.01 Billion. This endpoint is part of the forecast covering 2023 to 2033 and is used alongside the stated CAGR of 7%.
What is CAGR for the forecast period?
The compound annual growth rate (CAGR) for the period 2023 to 2033 is 7%, indicating steady expansion from the 2023 base to the 2033 projection.
Is there a single fastest Growing region in the Gastric Balloons Market Report market?
No single fastest-growing region is stated for the Gastric Balloons Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which product types are tracked in the report?
Product segmentation includes intragastric balloons and branded devices such as ORBERA and Revirol, with distinct sub-segments reported under the by-product classification.
Who are the leading companies noted in the research?
Top firms named in the study include Apollo Endosurgery, Ethicon Inc., and Allergan, representing major participants in product development and commercialization.
What end Users are included in the analysis?
End-user categories cover hospitals, clinics, and home care settings, with each channel evaluated for its role in device adoption and patient access.
What distribution channels does the report consider?
The report examines direct sales, online sales, and third-party distributors as primary distribution routes, assessing how each affects market reach and availability.